OpenLegislation

Article 4 Amendment of Schedule 2 to the principal order

Original text. Later amendments are not shown.

(1)

Schedule 2 to the principal order (which specifies the class of medicinal products, the subject of a product licence of right, on general sale by virtue of Article 2(b) of the principal order) is amended in accordance with the following paragraph of this article.

(2)

In Table A (internal or external use)—

(a)

there is added to column 1 the entry “Alexitol Sodium”,

(b)

there are deleted from column 1 the entries “Pennyroyal” and “Sodium Polyhydroxyaluminium Monocarbonate Hexitol Complex”, and

(c)

there are deleted from column 1 the entry “Salicylamide” and from columns 3 and 4 the entries relating to Salicylamide.